Search clinical trials for: Dacarbazine and bortezomib
Total 270459 results
-
Virginia Commonwealth UniversityCompletedMelanoma | Soft Tissue Sarcoma | Parathyroid Carcinoma | Small Cell Carcinoma of the Lung | Carcinoid TumorsUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisTerminatedSTAGE IIIB OR IV NON-SMALL CELL LUNG CANCERFrance
-
University of ZurichCompletedMelanoma Stage III or IV | No Prior ChemotherapySwitzerland
-
Genta IncorporatedCompletedMelanomaUnited States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
-
VicalCompletedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedMelanomaAustralia, United States
-
University Hospital, ToulouseDana-Farber Cancer Institute; Celgene Corporation; Janssen-Cilag Ltd.Completed
-
Simcere Pharmaceutical Co., LtdUnknownAdvanced Melanoma | Untreated PatientsChina
-
The First Affiliated Hospital of Soochow UniversityUnknownMultiple Myeloma Proved by Laboratory TestsChina
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompleted
-
Baylor College of MedicineMillennium Pharmaceuticals, Inc.CompletedProstate NeoplasmsUnited States
-
NCIC Clinical Trials GroupCompleted
-
University Hospital, Clermont-FerrandLaboratoires TakedaUnknownMultiple Myeloma | Adult | Bortezomib RegimenFrance
-
Janssen-Cilag International NVCompletedMultiple MyelomaTurkey, Greece, Czech Republic, Austria, Germany, Sweden, United Kingdom, Denmark
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
Nantes University HospitalCompleted
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
University of Erlangen-Nürnberg Medical SchoolWuerzburg University Hospital; University Hospital RegensburgRecruiting
-
National Cancer Institute (NCI)ExelisisCompletedStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal Melanoma | Stage III Uveal Melanoma AJCC v7 | Stage IIIA Uveal Melanoma AJCC v7 | Stage IIIB Uveal Melanoma AJCC v7 | Stage IIIC Uveal Melanoma AJCC v7United States, Canada
-
National Cancer Institute (NCI)CompletedIris Melanoma | Stage IV Uveal Melanoma | Medium/Large Size Posterior Uveal Melanoma | Recurrent Uveal Melanoma | Ocular Melanoma With Extraocular Extension | Small Size Posterior Uveal MelanomaUnited States, Canada
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated
-
University of RochesterCompletedMyelodysplastic SyndromesUnited States
-
Janssen Korea, Ltd., KoreaCompletedMultiple Myeloma
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedIslet Cell Tumor | Gastrointestinal Carcinoid TumorUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Completed
-
Janssen Pharmaceutical K.K.CompletedMultiple Myeloma | Relapse | Refractory
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Chinese SLE Treatment And Research GroupRecruiting
-
Weill Medical College of Cornell UniversityGlaxoSmithKline; Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
Indiana UniversityCompleted
-
National Cancer Institute (NCI)TerminatedGastrointestinal Cancer | Advanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder... and other conditionsUnited States
-
International Extranodal Lymphoma Study Group (IELSG)TerminatedLymphoma, Mucosa-Associated Lymphoid TissueSwitzerland
-
Janssen Korea, Ltd., KoreaCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
University of WuerzburgUnknownMultiple MyelomaAustria, Germany, Italy
-
National Cancer Institute (NCI)CompletedNon-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung CancerUnited States
-
Janssen-Cilag B.V.CompletedMultiple Myeloma | Hematological NeoplasmsNetherlands
-
Mayo ClinicNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States